血管紧张素转换酶和二肽基肽酶IV抑制剂：血管性水肿风险增加。 - Suppr

Angiotensin-converting enzyme and dipeptidyl peptidase IV inhibitors: an increased risk of angioedema.

作者信息

Grouzmann Eric, Livio Françoise, Buclin Thierry

出版信息

Hypertension. 2009 Sep;54(3):468-70. doi: 10.1161/HYPERTENSIONAHA.109.135244. Epub 2009 Jul 6.

DOI:10.1161/HYPERTENSIONAHA.109.135244

PMID:19581503

Abstract

摘要

相似文献

Angiotensin-converting enzyme and dipeptidyl peptidase IV inhibitors: an increased risk of angioedema.

Hypertension. 2009 Sep;54(3):468-70. doi: 10.1161/HYPERTENSIONAHA.109.135244. Epub 2009 Jul 6.

Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema.

Hypertension. 2009 Sep;54(3):516-23. doi: 10.1161/HYPERTENSIONAHA.109.134197. Epub 2009 Jul 6.

Dipeptidyl peptidase-4 inhibitors and angioedema: a class effect?

Diabet Med. 2013 Apr;30(4):e149-50. doi: 10.1111/dme.12134.

Dipeptidyl Peptidase-4 Inhibitor Induced Angioedema - An Overlooked Adverse Drug Reaction?

Curr Diabetes Rev. 2018;14(4):327-333. doi: 10.2174/1573399813666170214113856.

DPP-4 inhibitors and angioedema: a cause for concern?

Ann Allergy Asthma Immunol. 2011 May;106(5):436-8. doi: 10.1016/j.anai.2011.02.012. Epub 2011 Mar 22.

Is dipeptidylpeptidase IV the missing link in angiotensin-converting enzyme inhibitor--induced angioedema?

Hypertension. 2008 Jan;51(1):45-7. doi: 10.1161/HYPERTENSIONAHA.107.101329. Epub 2007 Nov 19.

Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema.

Hypertension. 2008 Jan;51(1):141-7. doi: 10.1161/HYPERTENSIONAHA.107.096552. Epub 2007 Nov 19.

Drug-Induced Inhibition of Angiotensin Converting Enzyme and Dipeptidyl Peptidase 4 Results in Nearly Therapy Resistant Bradykinin Induced Angioedema: A Case Report.

Am J Case Rep. 2017 May 25;18:576-579. doi: 10.12659/ajcr.901960.

A case report of bullous pemphigoid induced by dipeptidyl peptidase-4 inhibitors.

JAMA Dermatol. 2013 Feb;149(2):243-5. doi: 10.1001/jamadermatol.2013.1073.

Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.

J Clin Pharmacol. 2008 Jan;48(1):85-95. doi: 10.1177/0091270007307880. Epub 2007 Nov 6.

引用本文的文献

Assessment of Knowledge and General Attitudes of Primary Care Physicians Toward Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Drugs in the Management of Type 2 Diabetes Mellitus in the Qassim Region.

Cureus. 2025 Jun 29;17(6):e86948. doi: 10.7759/cureus.86948. eCollection 2025 Jun.

Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? .

Int J Mol Sci. 2022 Jun 30;23(13):7261. doi: 10.3390/ijms23137261.

Angioedema associated with dipeptidyl peptidase-IV inhibitors.

Clin Mol Allergy. 2021 Dec 6;19(1):24. doi: 10.1186/s12948-021-00164-7.

Sitagliptin- oleifera coadministration did not delay the progression nor ameliorated functional and morphological anomalies in alloxan-induced diabetic nephropathy.

Indian J Pharmacol. 2017 Sep-Oct;49(5):366-373. doi: 10.4103/ijp.IJP_832_16.

"Nuts and Bolts" of Laboratory Evaluation of Angioedema.

Clin Rev Allergy Immunol. 2016 Oct;51(2):140-51. doi: 10.1007/s12016-016-8539-6.

The opioid effects of gluten exorphins: asymptomatic celiac disease.

J Health Popul Nutr. 2015 Nov 24;33:24. doi: 10.1186/s41043-015-0032-y.

Factors affecting the development of adverse drug reactions (Review article).

Saudi Pharm J. 2014 Apr;22(2):83-94. doi: 10.1016/j.jsps.2013.02.003. Epub 2013 Feb 24.

Drug-induced angioedema: experience of Italian emergency departments.

Intern Emerg Med. 2014 Jun;9(4):455-62. doi: 10.1007/s11739-013-1007-x. Epub 2013 Nov 9.

Role of RACK1 in the differential proliferative effects of neuropeptide Y(1-36) and peptide YY(1-36) in SHR vs. WKY preglomerular vascular smooth muscle cells.

Am J Physiol Renal Physiol. 2013 Mar 15;304(6):F770-80. doi: 10.1152/ajprenal.00646.2012. Epub 2013 Jan 9.

Dipeptidylpeptidase-4 inhibitors (gliptins): focus on drug-drug interactions.

Clin Pharmacokinet. 2010 Sep;49(9):573-88. doi: 10.2165/11532980-000000000-00000.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Angiotensin-converting enzyme and dipeptidyl peptidase IV inhibitors: an increased risk of angioedema.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献